WeAreAllSculptra:First-of-its-KindGaldermaInitiativetoDemonstrateHowEveryoneCanBenefitfromSculptra’sRegenerativeProperties
===2026/2/12 19:06:48===
roducing the L-Lift: A Novel Approach To Treat Age-Related Facial Skin Ptosis Using A Collagen Stimulator. Dermatol Surg. 2020;46(8):1122-1124. doi: 10.1097/DSS.0000000000002015.
20.
Fabi S, et al. 24-month clinical trial data on effectiveness and safety after correction of cheek wrinkles using a biostimulatory poly-L-lactic acid injectable implant. Poster presented at AMWC. March 30 - April 1, 2023. Monte-Carlo, Monaco.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260211375008/en/
CONTACT:
For further information:
Christian Marcoux, M.Sc.
Chief Communications Officer
christian.marcoux@galderma.com
+41 76 315 26 50
Richard Harbinson
Corporate Communications Director
richard.harbinson@galderma.com
+41 76 210 60 62
Céline Buguet
Franchises and R&D Communications Director
celine.buguet@galderma.com
+41 76 249 90 87
=*=*=*=*=*=
当前为第12/13页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页